Track the abrdn Healthcare Investors share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €96.2m. The latest transaction was filed on 20 July 2026 (Acquisition). Among the most active insiders: Mahai Chris LaVictoire. The full history is free.
6
Insider Decl.
n/a
Thresholds
€67,178
6 ops.
Buy Volume
n/a
n/a
Sell Volume
38Σ signal
Buys €67,178n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,576 of 29,068 companies
75.0
score / 100
Value
82
Quality
68
FCF yld28%
Earn yld5.6%
EV/EBITDA·
ROE3.1%
Gross mgn·
Net mgn76%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,000 shares@ US$16.58100.0% of flowCommon StockSEC:0001104659-24-000357:0
Canonical exit: 27 Mar 2024 (T+90)
6 of 6 declarations
About abrdn Healthcare Investors
abrdn Healthcare Investors is an investment company focused on the healthcare sector. It aims to generate returns by investing in healthcare-related businesses.